Status:
UNKNOWN
Plan for Testing Fingerstick Bloods on Magellan Systems
Lead Sponsor:
Magellan Diagnostics
Conditions:
Lead Poisoning
Eligibility:
All Genders
Brief Summary
This study is to supplement our internal data that demonstrates the continued performance of capillary blood samples on Magellan's lead testing systems: LeadCare II, LeadCare Ultra (which have been cl...
Eligibility Criteria
Inclusion
- healthy subjects who consent to a capillary blood collection
Exclusion
- Patients are not currently taking chelating agents, e.g., penicillamine, succimer
Key Trial Info
Start Date :
July 31 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2017
Estimated Enrollment :
190 Patients enrolled
Trial Details
Trial ID
NCT03256383
Start Date
July 31 2017
End Date
August 31 2017
Last Update
August 22 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Associates, Inc.
Brockton, Massachusetts, United States, 02301
2
Pediatrics Associates, Inc
Hanson, Massachusetts, United States, 02341
3
Pediatrics Associates, Inc
West Bridgewater, Massachusetts, United States, 02379